Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.

The plant Cissus tuberosa Moc is abundant in phenolics, has been documented to have neuroprotective properties. The study seeks to determine the neuroprotective effects of C. tuberosa ethanolic extract (CTE) against Parkinson's disease by evaluating its impact on motor dysfunction, cognitive de...

Full description

Saved in:
Bibliographic Details
Main Authors: Malik Saadullah, Amna Sehar, Zunera Chauhdary, Rida Siddique, Hafsa Tariq, Muhammad Asif, Shazia Anwer Bukhari, Aisha Sethi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0311140
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850165365546418176
author Malik Saadullah
Amna Sehar
Zunera Chauhdary
Rida Siddique
Hafsa Tariq
Muhammad Asif
Shazia Anwer Bukhari
Aisha Sethi
author_facet Malik Saadullah
Amna Sehar
Zunera Chauhdary
Rida Siddique
Hafsa Tariq
Muhammad Asif
Shazia Anwer Bukhari
Aisha Sethi
author_sort Malik Saadullah
collection DOAJ
description The plant Cissus tuberosa Moc is abundant in phenolics, has been documented to have neuroprotective properties. The study seeks to determine the neuroprotective effects of C. tuberosa ethanolic extract (CTE) against Parkinson's disease by evaluating its impact on motor dysfunction, cognitive deficits, neuroinflammation, and neurodegeneration in paraquat-induced Parkinson's disease models. The research hypothesizes that CTE can modulate key biomarkers involved in Parkinson's pathology, including α-synuclein, interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α), assessed through qRT-PCR, as well as interleukin-6 (IL-6) and TNF-α, evaluated through ELISA. Parkinson disease was induced by using paraquat intraperitoneally. The study was designed by considering various groups with their respective treatments, control group treated normally, disease control receiving paraquat (1 mg/kg, i.p.), standard treated grabbed with (levodopa+carbidopa), and three treatment groups received plant extract (150, 300, 600 mg/kg) respectively for 21 days study period. Both behavioral, and biochemical analysis were performed. HPLC analysis revealed the presence of several phenolic compounds. CTE significantly improved motor function and cognitive performance in rats, showing a dose-dependent reduction in paraquat-induced neurotoxicity (150 < 300 < 600 mg/kg, P<0.001). CTE significantly restored antioxidant enzyme levels (P<0.001), contributing to the alleviation of oxidative stress. Neurotransmitter levels were significantly improved in a dose-dependent manner (P<0.001), while acetylcholinesterase (AChE) levels were significantly reduced (P<0.001). CTE treatment showed significant restoration of brain tissue, reducing neuroinflammation and neurodegeneration, thereby preserving normal brain structure. ELISA testing demonstrated a significant (P<0.001) downregulation of IL-6 and TNF-α levels in CTE-treated groups. qRT-PCR results showed significant downregulation of α-synuclein, IL-1β, and TNF-α mRNA expression in CTE-treated groups compared to the diseased group, suggesting neuroprotective effects. The study concludes that CTE has potential therapeutic effects in alleviating Parkinson's disease symptoms, primarily through its antioxidant, anti-inflammatory, and neuroprotective properties.
format Article
id doaj-art-53fdf1851fbf432f9ab52aeacff120e2
institution OA Journals
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-53fdf1851fbf432f9ab52aeacff120e22025-08-20T02:21:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031114010.1371/journal.pone.0311140Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.Malik SaadullahAmna SeharZunera ChauhdaryRida SiddiqueHafsa TariqMuhammad AsifShazia Anwer BukhariAisha SethiThe plant Cissus tuberosa Moc is abundant in phenolics, has been documented to have neuroprotective properties. The study seeks to determine the neuroprotective effects of C. tuberosa ethanolic extract (CTE) against Parkinson's disease by evaluating its impact on motor dysfunction, cognitive deficits, neuroinflammation, and neurodegeneration in paraquat-induced Parkinson's disease models. The research hypothesizes that CTE can modulate key biomarkers involved in Parkinson's pathology, including α-synuclein, interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α), assessed through qRT-PCR, as well as interleukin-6 (IL-6) and TNF-α, evaluated through ELISA. Parkinson disease was induced by using paraquat intraperitoneally. The study was designed by considering various groups with their respective treatments, control group treated normally, disease control receiving paraquat (1 mg/kg, i.p.), standard treated grabbed with (levodopa+carbidopa), and three treatment groups received plant extract (150, 300, 600 mg/kg) respectively for 21 days study period. Both behavioral, and biochemical analysis were performed. HPLC analysis revealed the presence of several phenolic compounds. CTE significantly improved motor function and cognitive performance in rats, showing a dose-dependent reduction in paraquat-induced neurotoxicity (150 < 300 < 600 mg/kg, P<0.001). CTE significantly restored antioxidant enzyme levels (P<0.001), contributing to the alleviation of oxidative stress. Neurotransmitter levels were significantly improved in a dose-dependent manner (P<0.001), while acetylcholinesterase (AChE) levels were significantly reduced (P<0.001). CTE treatment showed significant restoration of brain tissue, reducing neuroinflammation and neurodegeneration, thereby preserving normal brain structure. ELISA testing demonstrated a significant (P<0.001) downregulation of IL-6 and TNF-α levels in CTE-treated groups. qRT-PCR results showed significant downregulation of α-synuclein, IL-1β, and TNF-α mRNA expression in CTE-treated groups compared to the diseased group, suggesting neuroprotective effects. The study concludes that CTE has potential therapeutic effects in alleviating Parkinson's disease symptoms, primarily through its antioxidant, anti-inflammatory, and neuroprotective properties.https://doi.org/10.1371/journal.pone.0311140
spellingShingle Malik Saadullah
Amna Sehar
Zunera Chauhdary
Rida Siddique
Hafsa Tariq
Muhammad Asif
Shazia Anwer Bukhari
Aisha Sethi
Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
PLoS ONE
title Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
title_full Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
title_fullStr Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
title_full_unstemmed Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
title_short Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
title_sort anti neuroinflammatory and neuroprotective potential of cissus tuberosa ethanol extract in parkinson s disease model through the modulation of neuroinflammatory markers
url https://doi.org/10.1371/journal.pone.0311140
work_keys_str_mv AT maliksaadullah antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers
AT amnasehar antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers
AT zunerachauhdary antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers
AT ridasiddique antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers
AT hafsatariq antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers
AT muhammadasif antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers
AT shaziaanwerbukhari antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers
AT aishasethi antineuroinflammatoryandneuroprotectivepotentialofcissustuberosaethanolextractinparkinsonsdiseasemodelthroughthemodulationofneuroinflammatorymarkers